Gender Dysphoria: Prescriptions
The question
To ask the Secretary of State for Health and Social Care, what instructions his Department issued to NHS regional gender hubs on prescribing restrictions.
Answered by Karin Smyth
In March 2024, NHS England published its clinical policy on puberty suppressing hormones for children and young people who have gender incongruence and/or gender dysphoria.
This set out that puberty supressing hormones are not available as a routine commissioning treatment option for the treatment of children and young people who have gender incongruence and/or gender dysphoria.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →